tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Marie Thibault, 104 are a BUY (92.04%), 9 are a HOLD (7.96%).
Analyst Marie Thibault, currently employed at BTIG, carries an average stock price target met ratio of 54.27% that have a potential upside of 32.31% achieved within 141 days.
Marie Thibault’s has documented 228 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 30-Sep-2025.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/21/2021. The price target of $21 was fulfilled within 1 day with a profit of $2.58 (14.01%) receiving and performance score of 140.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$145
$10.41 (7.73%)
$137
2 months 21 days ago
(17-Jul-2025)
13/14 (92.86%)
$21.33 (17.25%)
369
Buy
$141
$6.41 (4.76%)
$142
2 months 21 days ago
(17-Jul-2025)
18/22 (81.82%)
$17.33 (14.01%)
376
Buy
$145
$10.41 (7.73%)
$139
2 months 21 days ago
(17-Jul-2025)
6/9 (66.67%)
$21.33 (17.25%)
753
Hold
$140
$5.41 (4.02%)
$130
2 months 23 days ago
(15-Jul-2025)
5/6 (83.33%)
$8.26 (6.27%)
125
Hold
$137
$2.41 (1.79%)
$127
2 months 24 days ago
(14-Jul-2025)
18/20 (90%)
$5.51 (4.19%)
452
Which stock is Marie Thibault is most bullish on?
Which stock is Marie Thibault is most reserved on?
What Year was the first public recommendation made by Marie Thibault?
